Albany, NY -- (SBWIRE) -- 08/09/2018 -- Dual chamber injectors and syringes aremedical devices used to store active pharmaceutical components or biological substances (such as tissue, blood or serum) that are not stable for extended period of time. These devices helps to maintain sterility of drugs before the time of injection in order to avoid drug loss.For example, liquid proteins drugs require refrigeration before dispensing thus, dual chamber injectors and syringes helps to manage proper storage condition of these drugs. Thus, proper storage of these drugs reduces the adverse effects of drug delivery.
Advancement in technology has introduced improved arrangement for liquid component in injectors and syringes. This advancement in technology may attract more number of customers to use these devices and hence drive the growth of these markets. Technology advancement has been further aided by launch of EZMix dual or multi chamber prefilled syringes by Unilife. EZMix serve as a safe and efficient system for reconstitution and delivery of injectable therapies. In addition, need for storage of biological substances and lyophilized drugs at freezing temperature before the use may drive the growth of dual chamber injectors and syringes markets. However, high cost of these devices may restrain the growth of Dual Chamber Injectors and Syringes Market.
Request to View Brochure of Report -
Geographically, North America and Europe dominates theglobal Dual Chamber Injectors and Syringe marketowing to increasing need to store lyophilized drug and maintain the stability of biological substances.In addition, Asia-Pacific region is anemerging market for the global dual chamber injectors and syringe.
Some of the key players contributing to the global Dual Chamber Injectors and Syringe marketcomprises Amylin Pharmaceuticals, LLC, Becton Dickinson, Hospira, SHL Medical, Vetter Pharma, and Ypsomed.
Enquiry for discount on this report -